Dalin Tzu Chi Hospital

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Lung cancer2 trials

Phase

• Phase 2/31 trial

Status

• Active, not recruiting1 trial
• Recruiting1 trial

Lead sponsor

• National Health Research Institutes, Taiwan1 trial
• Regeneron Pharmaceuticals1 trial

Running trials

• Active, not recruiting

  A Study to Learn if a Combination of Fianlimab and Cemiplimab Versus Cemiplimab Alone is More Effective for Adult Participants With Advanced Non-Small Cell Lung Cancer (NSCLC)

  NCT05785767· Phase 2/3· Regeneron Pharmaceuticals· Source

• Recruiting

  The Research Plan of Taiwan Precision Medicine

  NCT04849481· National Health Research Institutes, Taiwan· Source

  Contact: Chun-Liang Lai

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Lung cancer1 recruiting